Paper Details 
Original Abstract of the Article :
Infantile hemangioma (IH), formerly termed strawberry hemangioma, is a benign vascular tumor caused by capillary endothelial cell proliferation. The tumor regresses after 1 year of age, but sequelae occur in approximately half of the patients without systemic treatment. Propranolol (PPL) is currentl...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541900/

データ提供:米国国立医学図書館(NLM)

Propranolol: A Desert Mirage for Infantile Hemangiomas?

Infantile hemangiomas (IH), often called strawberry hemangiomas, are like colorful desert flowers, appearing on the skin of infants. While benign, they can cause complications in some cases. Propranolol (PPL) is a commonly used treatment, but this study highlights a potential side effect: severe hypoglycemia. The researchers emphasize the importance of being aware of this potential complication.

The study's findings serve as a cautionary tale, highlighting the need for vigilance when using PPL to treat IH. Severe hypoglycemia can pose a serious threat, especially in infants, emphasizing the importance of careful monitoring and early detection. The researchers underscore the importance of informing patients about the risks associated with PPL treatment.

Navigating the Desert of IH Treatment: Awareness is Key

This study highlights the importance of being aware of the potential risks associated with PPL treatment. Close monitoring and early detection of hypoglycemia are crucial to ensure patient safety.

The Desert of IH Treatment: A Balancing Act of Benefits and Risks

This study reminds us that while PPL offers benefits for treating IH, it's essential to be aware of the potential risks. Open communication between patients and doctors is crucial to ensure the safest and most effective treatment approach.

Dr.Camel's Conclusion

This study provides a valuable reminder about the potential for severe hypoglycemia as a side effect of PPL treatment for IH. It underscores the importance of careful monitoring and early detection of this complication to ensure patient safety. Like a desert traveler, we must be aware of the potential dangers that lie ahead and navigate the terrain with caution.

Date :
  1. Date Completed 2022-08-17
  2. Date Revised 2023-01-03
Further Info :

Pubmed ID

35972062

DOI: Digital Object Identifier

PMC9541900

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.